ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

InDex Pharmaceuticals · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
inflammatory-bowel-diseasesulcerative-colitis
ulcerative colitis, colitis, ulcerative, gastrointestinal disease, inflammatory bowel diseases, glucocorticosteroids, anti-inflammatory agents, therapeutic uses, cobitolimod, toll like receptor 9 agonist, tlr9 agonist, kappaproct, idx0150
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 982700
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.